Business Description
Central Pharmaceuticals Ltd
ISIN : BD0487CPL007
Total Employee Number:
75Compare
Compare
Traded in other countries / regions
CENTRALPHL.Bangladesh IPO Date
2013-08-14Description
Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished pharmaceutical formulations, including tablets, capsules, liquids, ointments, and injectables, covering therapeutic areas such as anti-infectives, cardiovascular treatments, pain management, and gastrointestinal remedies. It conducts production and sales exclusively in the domestic market through its own facilities and distribution network. The company generates revenue from the sales of its pharmaceutical preparations.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.58 | |||||
Debt-to-Equity | 0.33 | |||||
Debt-to-EBITDA | -12.25 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 0.18 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.3 | |||||
3-Year EBITDA Growth Rate | 64.3 | |||||
3-Year EPS without NRI Growth Rate | 37.1 | |||||
3-Year FCF Growth Rate | 23.7 | |||||
3-Year Book Growth Rate | 4.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.82 | |||||
9-Day RSI | 58.09 | |||||
14-Day RSI | 60.13 | |||||
3-1 Month Momentum % | 20.93 | |||||
6-1 Month Momentum % | 20.93 | |||||
12-1 Month Momentum % | -4.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.06 | |||||
Quick Ratio | 1.01 | |||||
Days Inventory | 154.28 | |||||
Days Sales Outstanding | 698.85 | |||||
Days Payable | 183.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -24.53 | |||||
Operating Margin % | -50.89 | |||||
Net Margin % | -52.02 | |||||
EBITDA Margin % | -60.71 | |||||
FCF Margin % | 0.02 | |||||
OCF Margin % | 0.02 | |||||
ROE % | -2.3 | |||||
ROA % | -1.32 | |||||
ROIC % | -1.22 | |||||
3-Year ROIIC % | 33.94 | |||||
ROC (Joel Greenblatt) % | -2.08 | |||||
ROCE % | -2.15 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 69.54 | |||||
PS Ratio | 38.39 | |||||
PB Ratio | 1.7 | |||||
Price-to-Tangible-Book | 1.69 | |||||
EV-to-EBIT | -71.46 | |||||
EV-to-EBITDA | -75.08 | |||||
EV-to-Revenue | 45.57 | |||||
EV-to-FCF | 170791.22 | |||||
Price-to-GF-Value | 0.95 | |||||
Price-to-Projected-FCF | 2.13 | |||||
Earnings Yield (Greenblatt) % | -1.4 | |||||
Forward Rate of Return (Yacktman) % | -39.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Central Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil BDT) | 36.096 | ||
| EPS (TTM) (BDT) | -0.166 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.2 | ||
| 3-Year Sortino Ratio | 0.34 | ||
| Volatility % | 31.9 | ||
| 14-Day RSI | 60.13 | ||
| 14-Day ATR (BDT) | 0.463791 | ||
| 20-Day SMA (BDT) | 11.055 | ||
| 12-1 Month Momentum % | -4.59 | ||
| 52-Week Range (BDT) | 7.1 - 12.5 | ||
| Shares Outstanding (Mil) | 119.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Central Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Central Pharmaceuticals Ltd Stock Events
| Event | Date | Price (BDT) | ||
|---|---|---|---|---|
| 1.05:1 Stock Split | 2018-11-26 | 16.10 (+0.00%) | ||
| 1.1:1 Stock Split | 2017-12-03 | 20.17 (+0.00%) | ||
| 1.1:1 Stock Split | 2016-11-20 | 10.94 (+0.00%) | ||
| 1.15:1 Stock Split | 2015-11-22 | 15.54 (+0.00%) | ||
| 1.15:1 Stock Split | 2014-09-30 | 22.20 (+0.00%) | ||
| 1.15:1 Stock Split | 2013-10-29 | 16.30 (+0.00%) |
Show
Entries
Central Pharmaceuticals Ltd Frequently Asked Questions
What is Central Pharmaceuticals Ltd(DHA:CENTRALPHL)'s stock price today?
The current price of DHA:CENTRALPHL is BDT11.50. The 52 week high of DHA:CENTRALPHL is BDT12.50 and 52 week low is BDT7.10.
When is next earnings date of Central Pharmaceuticals Ltd(DHA:CENTRALPHL)?
The next earnings date of Central Pharmaceuticals Ltd(DHA:CENTRALPHL) is .
Does Central Pharmaceuticals Ltd(DHA:CENTRALPHL) pay dividends? If so, how much?
Central Pharmaceuticals Ltd(DHA:CENTRALPHL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Central Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers